Teams at Spyre Therapeutics

Lead biostatistics for clinical development programs: design trials, author SAPs/protocol statistical sections, manage biometrics team and vendors, perform/adjudicate analyses, support regulatory interactions, and build standards/processes.

Physician leader responsible for strategic and operational oversight of IBD antibody clinical development. Lead the Phase 2 platform trial, drive protocol development, medical review, safety oversight, data interpretation, and regulatory interactions. Partner cross-functionally to design and execute trials, chair governance committees, mentor clinical teams, and shape registrational strategy and program-level decisions.